Cypher AI raises $2 million seed round to build unified R&D platform for life science teams

Cypher AI raised $2 million in seed funding to replace spreadsheets in biotech research with a single platform covering experiment design, data analysis, and vendor management. Over 800 scientists have already run 100,000+ workflows through it.

Categorized in: AI News Science and Research
Published on: May 29, 2026
Cypher AI raises $2 million seed round to build unified R&D platform for life science teams

Cypher AI Raises $2 Million to Replace Spreadsheets With AI Lab Infrastructure

Cypher AI, a startup building software infrastructure for biotech research teams, announced $2 million in seed funding led by MaC Venture Capital. The round included participation from Epsilon Ventures, Connecticut Innovations, Sparta Group, and LiquidMetal Ventures.

The company consolidates experiment design, execution, data analysis, and vendor management into a single platform. Most life science teams still run research workflows through spreadsheets and disconnected documentation systems, the company said.

Cypher AI launched in 2025 and has already gained traction with biotech companies including DropGenie, Flock Bio, Bioqore, and WayBio. More than 800 scientists have run over 100,000 laboratory and computational workflows through the platform to date.

What the Platform Does

The software combines laboratory information management, electronic lab notebooks, workflow orchestration, and AI-driven analysis. Rather than treating research as a static process, Cypher AI's system adapts as scientific workflows change.

Founder and CEO Yaoyu Yang said the platform replaces fragmented tools with "an AI-native platform built for dynamic scientific environments," allowing researchers to design experiments, coordinate execution, manage vendors, and analyze results in one place.

Early Customer Feedback

Josh Hinckley, CEO of Bioqore, said the infrastructure allows biotech companies to scale differently. "Adding a new organism or a new client doesn't mean rebuilding the stack," he said in a statement.

Adrian Fenty, an investor at MaC Venture Capital, said Cypher AI is "rethinking the operating system for life science R&D" rather than simply improving existing lab software.

The funding will support expansion into pharmaceutical and research organizations.

For researchers managing complex workflows, understanding how AI Agents & Automation apply to laboratory work offers practical context. Learn more about AI for Science & Research applications.


Get Daily AI News

Your membership also unlocks:

700+ AI Courses
700+ Certifications
Personalized AI Learning Plan
6500+ AI Tools (no Ads)
Daily AI News by job industry (no Ads)